Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs BRAWN BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS BRAWN BIOTECH NOVARTIS/
BRAWN BIOTECH
 
P/E (TTM) x 26.5 -4.8 - View Chart
P/BV x 3.3 1.0 343.4% View Chart
Dividend Yield % 4.6 0.0 -  

Financials

 NOVARTIS   BRAWN BIOTECH
EQUITY SHARE DATA
    NOVARTIS
Mar-23
BRAWN BIOTECH
Mar-23
NOVARTIS/
BRAWN BIOTECH
5-Yr Chart
Click to enlarge
High Rs76323 3,340.3%   
Low Rs55414 4,073.5%   
Sales per share (Unadj.) Rs153.474.1 207.0%  
Earnings per share (Unadj.) Rs41.9-2.9 -1,446.9%  
Cash flow per share (Unadj.) Rs44.3-2.5 -1,751.7%  
Dividends per share (Unadj.) Rs47.500-  
Avg Dividend yield %7.20-  
Book value per share (Unadj.) Rs314.221.0 1,493.9%  
Shares outstanding (eoy) m24.693.00 823.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.30.2 1,745.7%   
Avg P/E ratio x15.7-6.3 -249.8%  
P/CF ratio (eoy) x14.9-7.2 -206.3%  
Price / Book Value ratio x2.10.9 241.9%  
Dividend payout %113.50-   
Avg Mkt Cap Rs m16,26255 29,740.3%   
No. of employees `000NANA-   
Total wages/salary Rs m35614 2,547.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,787222 1,703.7%  
Other income Rs m5810 645,666.7%   
Total revenues Rs m4,369222 1,964.3%   
Gross profit Rs m651-3 -21,549.7%  
Depreciation Rs m611 5,559.6%   
Interest Rs m180 19,444.4%   
Profit before tax Rs m1,154-4 -28,004.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1205 2,630.2%   
Profit after tax Rs m1,034-9 -11,907.8%  
Gross profit margin %17.2-1.4 -1,263.9%  
Effective tax rate %10.4-110.8 -9.4%   
Net profit margin %27.3-3.9 -698.8%  
BALANCE SHEET DATA
Current assets Rs m7,861134 5,866.6%   
Current liabilities Rs m2,68380 3,333.7%   
Net working cap to sales %136.724.1 567.8%  
Current ratio x2.91.7 176.0%  
Inventory Days Days1,20110 12,205.8%  
Debtors Days Days3587,270 0.0%  
Net fixed assets Rs m12,65610 130,204.7%   
Share capital Rs m12330 411.3%   
"Free" reserves Rs m7,63433 23,069.2%   
Net worth Rs m7,75763 12,295.1%   
Long term debt Rs m00-   
Total assets Rs m20,517144 14,276.6%  
Interest coverage x66.9-44.7 -149.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.21.5 11.9%   
Return on assets %5.1-6.0 -85.7%  
Return on equity %13.3-13.8 -96.8%  
Return on capital %15.1-6.4 -236.9%  
Exports to sales %2.10-   
Imports to sales %00-   
Exports (fob) Rs m80NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m800-   
Fx outflow Rs m9460-   
Net fx Rs m-8660-   
CASH FLOW
From Operations Rs m4483 14,088.1%  
From Investments Rs m-1,533-1 159,635.4%  
From Financial Activity Rs m-305NA 381,000.0%  
Net Cashflow Rs m-1,3892 -64,920.6%  

Share Holding

Indian Promoters % 0.0 53.7 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 0.7 0.6 120.3%  
FIIs % 0.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 46.3 63.4%  
Shareholders   43,128 6,139 702.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   ADANI ENTERPRISES    MMTC    REDINGTON    SIRCA PAINTS INDIA    LLOYDS ENTERPRISES    


More on Novartis vs BRAWN PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Novartis vs BRAWN PHARMA Share Price Performance

Period Novartis BRAWN PHARMA S&P BSE HEALTHCARE
1-Day -0.45% 4.99% 1.18%
1-Month 7.21% -8.88% -0.75%
1-Year 81.18% 25.94% 61.82%
3-Year CAGR 23.02% -2.98% 18.16%
5-Year CAGR 8.42% -11.53% 19.79%

* Compound Annual Growth Rate

Here are more details on the Novartis share price and the BRAWN PHARMA share price.

Moving on to shareholding structures...

The promoters of Novartis hold a 70.7% stake in the company. In case of BRAWN PHARMA the stake stands at 53.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Novartis and the shareholding pattern of BRAWN PHARMA.

Finally, a word on dividends...

In the most recent financial year, Novartis paid a dividend of Rs 47.5 per share. This amounted to a Dividend Payout ratio of 113.5%.

BRAWN PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Novartis, and the dividend history of BRAWN PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.